Volume 3.18 | May 12

Cord Blood News 3.18, May 12, 2011
     In this issue: Science News | Current Publications | Industry News | Policy News | Events
Cell Therapy News on Facebook  Cord Blood News on Twitter

Asthma-Associated Polymorphisms in 17q21 Influence Cord Blood ORMDL3 and GSDMA Gene Expression and IL-17 Secretion
Researchers investigated the relation between polymorphisms and mRNA expression of 17q21 locus genes and their influence on T-cell subsets in cord blood. [J Allergy Clin Immunol]



Adalimumab Levels Detected in Cord Blood and Infants Exposed in Utero, Researchers Report
Adalimumab, a drug often prescribed for women with Crohn’s disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn’s bloodstream for at least three months, researchers have found. [Press release from ScienceDaily discussing research presented at Digestive Disease Week 2011]

Study Reveals Origins of a Cancer Affecting the Blood And Bone Marrow
A new study sheds light on the origins of myeloid leukemia, a type of blood cancer that affects children and adults. The researchers discovered that novel mutations in an intracellular communication pathway called Notch led to the cancer, pointing to a potential new target for treating this disease. [Press release from the NYU Cancer Institute discussing online prepublication in Nature]

Low Vitamin D At Birth Raises Lung Infection Risk Six Fold
Researchers, having already suspected that low vitamin D is closely linked to RSV vulnerability, set out to measure vitamin D levels in the cord blood of 156 newborn babies. [Press release from Medical News today discussing online prepublication in Pediatrics

Need to expand CD34+ cells?
StemSpan® serum-free expansion media are optimized for expanding hematopoietic stem and progenitor cells

CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

A Novel Tumour-Suppressor Function for the Notch Pathway in Myeloid Leukaemia
Here researchers identify novel somatic-inactivating Notch pathway mutations in a fraction of patients with chronic myelomonocytic leukaemia (CMML). [Nature]

Efficient Generation of Hematopoietic Precursors and Progenitors From Human Pluripotent Stem Cell Lines
The data add to the cumulating evidence for the existence of an in vitro derived precursor to the hematopoietic stem cell with limited engrafting ability in transplanted mice, but with multipotent hematopoietic potential. [Stem Cells]

An Overview of the Progress on Double Umbilical Cord Blood Transplantation
Herein a brief overview of the clinical experience on double umbilical cord blood transplantation and the underlying biology is presented. [Haematologica]

Optimal Conditions for Lentiviral Transduction of Engrafting Human CD34+ Cells
In summary, 24h prestimulation followed by single 24-h lentiviral transduction in serum-free media with SCF, FLT3 ligand and thrombopoietin yields high transduction efficiency to engrafting human CD34+ cells, and is applicable in human clinical gene therapy trials. [Gene Ther]

Cord Blood Vitamin D Deficiency is Associated With Respiratory Syncytial Virus Bronchiolitis
The objective of this study was to determine the association between plasma vitamin D concentrations at birth and the subsequent risk of RSV LRTI. [Pediatrics]

Human CD34+ CD133+ Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ−/− (NSG) Mice
Here, researchers expanded cord blood CD34+ CD133+ cells in a defined medium containing angiopoietin like 5 and insulin-like growth factor binding protein 2 and evaluated the cells for stem cell activity in NOD-SCID Il2rg−/− (NSG) mice by multi-lineage engraftment, long term reconstitution, limiting dilution and serial reconstitution. [PLoS ONE]

Effects of CXCR1 and CXCR2 Inhibition on Expansion and Differentiation of Umbilical Cord Blood CD133+ Cells into Megakaryocyte Progenitor Cells
In the present study, researchers investigated the effects of CXCR1 and/or CXCR2 inhibition on expansion and differentiation of umbilical cord blood CD133+ cells into megakaryocytic progenitors. [Cytokine]
Clinical Analysis of the Treatment of Spinocerebellar Ataxia and Multiple System Atrophy-Cerebellar Type with Umbilical Cord Mesenchymal Stromal Cells
The aims of this study were to observe the safety and effectiveness of umbilical cord mesenchymal stromal cells in the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type. [Cytotherapy]

Terminal Maturation of Megakaryocytes and Platelet Production by Hematopoietic Stem Cells Irradiated with Heavy-Ion Beams
This study examined the terminal maturation of megakaryocytes and platelet production derived from hematopoietic stem cells irradiated with heavy-ion beams. [Radiat Res]

Enhanced Neogenic Potential of Panc-1 Cells Supplemented with Human Umbilical Cord Blood Serum—An Alternative to FCS
In the present study researchers investigated the effects of human umbilical cord blood serum and fetal calf serum (FCS) on the proliferation (viability, proliferative) and its differentiation potential (DTZ staining, immunofluroscence) to generate islet like cellular aggregates using the human derived Panc-1 cell lines. [Tissue Cell]


CordLife Performs India’s First Successful Mixed Stem Cell Transplantation
On 3rd April 2011, the stem cell transplantation was carried out by Dr. Ashish Mukherjee at the Netaji Subhash Cancer Research Institute and this is the first time that a mixed stem cell transplant (cord blood and bone marrow) has been performed in India. [CordLife Press Release]

Cord Blood America’s South American Company Opens Miami Office; Expands in Argentina
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced that Biocordcell Argentina S.A. (BioCells, Inc.) is opening an office in Miami, Florida and 5 new offices in Argentina. [Cord Blood America, Inc. Press Release]

Cord Blood America Stock Split Update
Cord Blood America, Inc. announced that the effective date for the reverse split, approved by 80 percent of its shareholders voting in a recent proxy vote, is the opening of the market on Monday, May 9, 2011. [Cord Blood America, Inc. Press Release]

Ohio State Leukemia Expert To Join National Academy
Dr. Clara D. Bloomfield is among 212 leaders in the sciences, social sciences, humanities, the arts, business and public affairs who are members of the 2011 class of the American Academy of Arts and Sciences. [The Ohio State University Medical Center Press Release]

National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
NEW Stem Cells in Development and Disease 2011
September 11-14, 2011
Berlin, Germany

Visit our events page to see a complete list of events in the cord blood community.

Implementation Coordinator – Maternity Leave Contract (STEMSOFT Software Inc.)

Quality Assurance Manager – Program in Children’s Regenerative Medicine (The University of Texas Medical School at Houston)

Supervisor Cell Therapy Laboratory – Cord Blood Bank (The University of Texas MD Anderson Cancer Center)

Supervisor Cell Therapy Lab (The University of Texas MD Anderson Cancer Center)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally: United States, Canada, Europe, Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in Cord Blood News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Cord Blood News: Archives | Events | Contact Us